NFKB1 and breast cancer: Similarly, miR-328-3p has been shown to target and regulate COL1A1, associated with the elastic parameters of breast lesions [128,129], and miR-423-5p enhanced the NF-κB signaling activation pathway by directly targeting TNIP2, the vital negative regulator of the NF-κB pathway, finely modulating BC invasiveness [130].